Ernest Moniz Discusses the Future of Nuclear Weapons with Santa Fe Panel on the Arts
NTI CEO and Co-Chair Ernest J. Moniz participated in a panel discussion about the future of nuclear weapons.
NTI Leadership and Staff Play Key Role in Major International Nuclear Materials Conference
NTI VP Corey Hinderstein and other NTI leaders and staff are playing a key role as the INMM hosts its 59th annual meeting this week in Baltimore, MD.
Article
Biosecurity Innovation and Risk Reduction Initiative
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
South Korean Foreign Minister Kang on Prospects for Peace on the Korean Peninsula
Ernest J. Moniz Discusses the Helsinki Summit on MSNBC
NTI Co-Chair and CEO Ernest J. Moniz appeared on MSNBC Anchor Chris Jansing to discuss the results of the Helsinki Summit July 17, 2018.
Sam Nunn discusses Helsinki Summit on Bloomberg TV
NTI Co-Chair Sam Nunn discusses the Helsinki Summit with Bloomberg Anchors Shery Ahn and Kevin Cirilli on July 17, 2018.
Trump-Putin summit an essential step to reducing nuclear danger
NTI CEO and Co-Chair Ernest J. Moniz and NTI Co-Chair Sam Nunn highlight the need for US-Russia dialogue to reduce nuclear dangers ahead of the Helsinki Summit. Originally published in The Hill.
NTI Experts Available to Discuss Trump-Putin Summit
Nuclear issues are expected to be on the agenda when Presidents Trump and Putin are scheduled to meet in Helsinki, Finland on Monday, July 16, 2018.
NTI to Launch Global Health Security Index with New Grant from the Open Philanthropy Project
NTI | bio will create a Global Health Security Index to serve as an assessment of all countries’ capabilities to prevent, detect, and respond to biological events.